Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Deciphering the Intent Behind the Inclusion of FDA Regulatory Terminology in the AMP Draft Rule

June 27, 2012, American Conference Institute In-House Counsel Forum on Government Regulation of Prescription Drug Pricing, New York, NY

Share this article: